There is no significant difference in cancer outcomes, including cancer-related death, between transgender women and cisgender men, according to a study published in Cancer. Research is yet to determine the implication of hormonal manipulation for the aggressiveness of prostate cancer in transgender women. ...
Disparities in Prostate Cancer
Advertisement
These findings highlight the importance of racial diversity in genomic profiling and clinical trials.
Men aged 60-69 years had a decreased risk of death with the addition of androgen deprivation therapy.
The adoption of polyethylene glycol hydrogel spacer use in prostate cancer care has been slower in Black patients.
Guideline-concordant androgen deprivation therapy is associated with a survival benefit in high-risk prostate cancer.
Patients who underwent radical prostatectomy also had a higher likelihood of decision regret.
Both Fluciclovine and PSMA PET/CT guided radiation therapy would significantly change pre-PET radiation therapy volumes.
P-CARE integrates genetics, family history, and ancestry to offer a more objective risk assessment.
After 10 years, 3.3% of patients who were recurrence-free developed distant metastasis.
Advertisement
Expert Interviews
Drs. Julia Schulz and Michael Dovidio discuss lab values to determine GLP-1 drug coverage and improve prescription access.
Dr. Kamal Golla of Evolent discusses specialist engagement with primary care physicians for high-quality patient care.
Patient advocate and influencer Alisha Bridges talks about living with Plaque & Scalp Psoriasis as a person of color.
Dr. Luke Twelves, VP of Medical for Lindus Health discusses the lack of diversity in type 2 diabetes clinical trials.
Dr. Amy McMichael discusses plaque psoriasis on skin of color and Johnson & Johnson's VISIBLE study.
Dr. Daniel Von Hoff Discusses what the $150M Stephenson Prize means for pancreatic cancer research.
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.